Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04537390 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Anti-mullerian Hormone Levels in Healthy Females

Study acronym: AMH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site contact updatedv3
  2. Primary completion date: Dec 1, 2021 to Dec 1, 2030
    • Study completion date: Jul 1, 2022 to Dec 1, 2030
    • Site contact updated
    • Collaborators expanded, about 9 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to have a better understanding of the normal blood levels of AMH in females from 0-18 years of age and how the blood AMH levels correspond to a female's reproductive development.
Trial Details
NCT Number NCT04537390
Lead Sponsor Erin Rowell
Collaborators: Ann & Robert H Lurie Children's Hospital of Chicago
Conditions
(from sponsor)		 Healthy
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov